Evaluation of soluble B7x as a serum marker in patients with clear cell renal cell carcinoma

被引:1
|
作者
Thompson, R. H.
Zang, X.
Lohse, C. M.
Leibovich, B. C.
Slovin, S. F.
Reuter, V. E.
Blute, M. L.
Russo, P.
Kwon, E. D.
Allison, J. P.
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mayo Clin, Rochester, MN USA
关键词
D O I
10.1200/jco.2008.26.15_suppl.5052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5052
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage
    Thompson, R. Houston
    Zang, Xingxing
    Lohse, Christine M.
    Leibovich, Bradley C.
    Slovin, Susan F.
    Reuter, Victor E.
    Cheville, John C.
    Blute, Michael L.
    Russo, Paul
    Kwon, Eugene D.
    Allison, James P.
    [J]. CANCER RESEARCH, 2008, 68 (15) : 6054 - 6058
  • [2] Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma
    Azuma, Takeshi
    Sato, Yujiro
    Ohno, Tetsukuni
    Azuma, Miyuki
    Kume, Haruki
    [J]. PLOS ONE, 2018, 13 (07):
  • [3] Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
    Gigante, Margherita
    Lucarelli, Giuseppe
    Divella, Chiara
    Netti, Giuseppe Stefano
    Pontrelli, Paola
    Cafiero, Cesira
    Grandaliano, Giuseppe
    Castellano, Giuseppe
    Rutigliano, Monica
    Stallone, Giovanni
    Bettocchi, Carlo
    Ditonno, Pasquale
    Gesualdo, Loreto
    Battaglia, Michele
    Ranieri, Elena
    [J]. MEDICINE, 2015, 94 (45) : e1917
  • [4] Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma (vol 13, e0199719, 2018)
    Azuma, T.
    Sato, Y.
    Ohno, T.
    Azuma, M.
    Kume, H.
    [J]. PLOS ONE, 2018, 13 (08):
  • [5] FABP7 AS A POTENTIAL TARGET AND MARKER IN CLEAR CELL RENAL CELL CARCINOMA
    Nagao, Kazuhiro
    Shinohara, Nachi
    Smit, Frank
    Jannink, Sander
    de Weijert, Mirjam
    Kobayashi, Keita
    Kawai, Yoshihisa
    Matsumoto, Hiroaki
    Hara, Takahiko
    Matsuyama, Hideyasu
    Owada, Yuji
    Mulders, Peter
    Oosterwijk, Egbert
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E311 - E311
  • [6] miR-10b is a prognostic marker in clear cell renal cell carcinoma
    Khella, Heba W. Z.
    Daniel, Nicole
    Youssef, Leza
    Scorilas, Andreas
    Nofech-Mozes, Roy
    Mirham, Lorna
    Krylov, Sergey N.
    Liandeau, Evi
    Krizova, Adriana
    Finelli, Antonio
    Cheng, Yufeng
    Yousef, George M.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (10) : 854 - 859
  • [7] Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma
    Masuda, Akinori
    Arai, Kyoko
    Nishihara, Daisaku
    Mizuno, Tomoya
    Yuki, Hideo
    Kambara, Tsunehito
    Betsunoh, Hironori
    Abe, Hideyuki
    Yashi, Masahiro
    Fukabori, Yoshitatsu
    Yoshida, Ken-Ichiro
    Kamai, Takao
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [8] Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma
    Li, Wei
    Liu, Min
    Feng, Yuan
    Xu, Yun-Fei
    Che, Jian-Ping
    Wang, Guang-Chun
    Zheng, Jun-Hua
    Gao, Heng-Jun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (06): : 1086 - 1094
  • [9] Fatty acid binding protein 7: A novel marker for clear cell renal cell carcinoma
    Kasper, K. A.
    Zhang, J. F.
    Lin, F.
    Petillo, D.
    Westphal, M.
    Luan, C.
    Teh, B. T.
    Yang, X. J.
    [J]. MODERN PATHOLOGY, 2008, 21 : 163A - 163A
  • [10] Fatty acid binding protein 7: A novel marker for clear cell renal cell carcinoma
    Kasper, K. A.
    Zhang, J. F.
    Lin, F.
    Petillo, D.
    Westphal, M.
    Luan, C.
    Teh, B. T.
    Yang, X. J.
    [J]. LABORATORY INVESTIGATION, 2008, 88 : 163A - 163A